Piramal Pharma Limited - Asset Resilience Ratio

Latest as of March 2026: 0.73%

Piramal Pharma Limited (PPLPHARMA) has an Asset Resilience Ratio of 0.73% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Piramal Pharma Limited leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Liquid Assets

Rs1.32 Billion

≈ $14.25 Million USD Cash + Short-term Investments

Total Assets

Rs179.65 Billion

≈ $1.94 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2026)

This chart shows how Piramal Pharma Limited's Asset Resilience Ratio has changed over time. See Piramal Pharma Limited balance sheet independence to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Piramal Pharma Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Piramal Pharma Limited stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs1.32 Billion	0.73%
Total Liquid Assets	Rs1.32 Billion	0.73%

Asset Resilience Insights

Limited Liquidity: Piramal Pharma Limited maintains only 0.73% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Piramal Pharma Limited Industry Peers by Asset Resilience Ratio

Compare Piramal Pharma Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	0.76%
Eris Lifesciences Limited NSE:ERIS	Drug Manufacturers - Specialty & Generic	0.58%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.01%
Lotus Pharmaceutical Co Ltd TW:1795	Drug Manufacturers - Specialty & Generic	0.49%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	11.69%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	18.70%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Sun Pharma Advanced Research Company Limited NSE:SPARC	Drug Manufacturers - Specialty & Generic	0.64%

Annual Asset Resilience Ratio for Piramal Pharma Limited (2021–2026)

The table below shows the annual Asset Resilience Ratio data for Piramal Pharma Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2026-03-31	0.73%	Rs1.32 Billion ≈ $14.25 Million	Rs179.65 Billion ≈ $1.94 Billion	+0.61pp
2025-03-31	0.12%	Rs195.60 Million ≈ $2.12 Million	Rs156.78 Billion ≈ $1.70 Billion	-0.82pp
2024-03-31	0.94%	Rs1.45 Billion ≈ $15.65 Million	Rs153.12 Billion ≈ $1.66 Billion	+0.94pp
2023-03-31	0.00%	Rs1.00 Million ≈ $10.81K	Rs145.23 Billion ≈ $1.57 Billion	-0.42pp
2022-03-31	0.42%	Rs543.20 Million ≈ $5.87 Million	Rs127.97 Billion ≈ $1.38 Billion	+0.15pp
2021-03-31	0.27%	Rs156.40 Million ≈ $1.69 Million	Rs57.57 Billion ≈ $622.56 Million	--

pp = percentage points

About Piramal Pharma Limited

NSE:PPLPHARMA India Drug Manufacturers - Specialty & Generic

Market Cap

$2.28 Billion

Rs210.50 Billion INR

Market Cap Rank

#5889 Global

#258 in India

Share Price

Rs158.90

Change (1 day)

-0.81%

52-Week Range

Rs133.27 - Rs216.88

All Time High

Rs293.55